Minnema M, Nasserinejad K, Hazenberg B, et al. HOVON 104: results from a multicenter, prospective phase II study of bortezomib based induction treatment followed by autoogous stem cell transplantation in patients with de novo AL amyloidosis. EHA 2017, abstract S411.
Effectiviteit en veiligheid van efgartigimod bij primaire immuuntrombocytopenie
jan 2024 | Benigne hematologie